Year archive

SUDARSHAN PHARMA INDUSTRIES LIMITED — 2026 filings

All 9 regulatory filings released by SUDARSHAN PHARMA INDUSTRIES LIMITED (543828) in 2026, sourced directly from the official regulator.

9 Filings

2026 Period

2026 filings (9)

Filing	Released	Lang
We refer to the Corporate Announcement dated May 15, 2026, (Annexure A) setting out fixed conversion rate of Rs.95.93 per US Dollar for FCCB issue. RBI rate as on date of signing subscription .... Capital/Financing Update	2026-05-21	English
The Board of DIrectors at their meeting held today, 21/May/2026, inter alia, approved the following: 1) Migration of equity shares to main Board of BSE and NSE 2) Making Application .... Regulatory Filings	2026-05-21	English
Allotment of USD 10,000,000 8% Senior Unsecured Foreign Currency COnvertible Bonds Due 2029 of the Company. Capital/Financing Update	2026-05-21	English
The Board Meeting to be held on 22/05/2026 has been revised to 21/05/2026 The Board Meeting to be held on 22/05/2026 has been revised to 21/05/2026 Regulatory Filings	2026-05-18	English
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/05/2026 ,inter alia, to consider and approve (1) Migration of .... Regulatory Filings	2026-05-18	English
We refer to your email dated 16/05/2026 seeking additional details for the Outcome of Board Meeting made by the Company 15/05/2026 pertaining to approval of upto US $20,000,000 of 8% Senior .... Capital/Financing Update	2026-05-18	English
In terms of Regulation 30 read with Para A of Part A of Schedule III to SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, we hereby submit the updated Investor Presentation Investor Presentation	2026-05-15	English
In continuation to our earlier communication dated May 12, 2026, and in terms of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to .... Capital/Financing Update	2026-05-15	English
Sudarshan Pharma Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/05/2026 ,inter alia, to consider and approve the proposal for .... Regulatory Filings	2026-05-12	English